Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
100
Value
$1.60K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026100$1.60K<0.1%00.0%UnchangedHolders
Q1 2026100$1.85K<0.1%00.0%UnchangedHolders
Q4 2025100$1.56K<0.1%00.0%UnchangedHolders
Q3 2025100$1.46K<0.1%00.0%UnchangedHolders
Q2 2025100$1.55K<0.1%00.0%UnchangedHolders
Q1 2025100$1.49K<0.1%00.0%UnchangedHolders
Q4 2024100$1.32K<0.1%00.0%UnchangedHolders
Q3 2024100$1.42K<0.1%00.0%UnchangedHolders
Q2 2024100$1.29K<0.1%00.0%UnchangedHolders
Q1 2024100$1.39K<0.1%−186−65.0%ReducedHolders
Q4 2023286$4.08K<0.1%−503−63.8%ReducedHolders
Q3 2023789$12.2K<0.1%+503+175.9%AddedHolders
Q2 2023286$4.49K<0.1%00.0%UnchangedHolders
Q1 2023286$4.71K<0.1%−105−26.9%ReducedHolders
Q4 2022391$6.10K<0.1%+105+36.7%AddedHolders
Q3 2022286$4.00K<0.1%00.0%UnchangedHolders
Q2 2022286$4.00K<0.1%00.0%UnchangedHolders
Q1 2022286$4.00K<0.1%−745−72.3%ReducedHolders
Q4 20211,031$14.0K<0.1%00.0%UnchangedHolders
Q3 20211,031$17.0K<0.1%00.0%UnchangedHolders
Q2 20211,031$17.0K<0.1%−10−1.0%ReducedHolders
Q1 20211,041$19.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.